Neurogene (NGNE) Current Assets (2013 - 2026)
Neurogene (NGNE) reported Current Assets of $228.91 million for Q2 2026, down 17.9% from $278.99 million a year earlier and down 7.2% from the prior quarter.
Powered by 
Analysis
Neurogene (NGNE) Current Assets (2013 - 2026) Analysis & Trends
At the end of FY2025, Neurogene posted Current Assets of $271.77 million, down 14.0% from FY2024.
- Current Assets has a five-year compound annual growth rate of 6.9% (FY2020 to FY2025).
- By year, Current Assets came in at $315.92 million in FY2024 (+57.7%), $200.35 million in FY2023 (+136.5%), $84.72 million in FY2022 (-41.2%) and $143.99 million in FY2021 (-26.0%).
- The Q2 2026 figure ranks as the lowest quarterly Current Assets since Q3 2024.
- Year over year, Current Assets has now declined in each of the last three quarters, with growth averaging 40.3% over the last eight quarters.
- The high point for year-over-year Current Assets in five years was Q4 2023 (growth of 136.5%); the low point was Q4 2022 (a decline of 41.2%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $246.75 million (Q1 2026), $271.77 million (Q4 2025) and $270.52 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 27.97 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.96 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 13.95 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 41.36 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 12.54 Bn |
| 10 | Neurogene | 642.28 Mn | 642.28 Mn | - | 228.91 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 228.91 Mn |
| Mar 31, 2026 | 246.75 Mn |
| Dec 31, 2025 | 271.77 Mn |
| Sep 30, 2025 | 270.52 Mn |
| Jun 30, 2025 | 278.99 Mn |
| Mar 31, 2025 | 296.40 Mn |
| Dec 31, 2024 | 315.92 Mn |
| Sep 30, 2024 | 143.65 Mn |
| Jun 30, 2024 | 159.15 Mn |
| Mar 31, 2024 | 174.14 Mn |
| Dec 31, 2023 | 200.35 Mn |
| Sep 30, 2023 | 79.89 Mn |
| Jun 30, 2023 | 83.78 Mn |
| Mar 31, 2023 | 85.64 Mn |
| Dec 31, 2022 | 84.72 Mn |
| Sep 30, 2022 | 108.86 Mn |
| Jun 30, 2022 | 118.49 Mn |
| Mar 31, 2022 | 130.37 Mn |
| Dec 31, 2021 | 143.99 Mn |
| Sep 30, 2021 | 156.50 Mn |
API Access
Neurogene Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=NGNE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "NGNE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=NGNE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();